Prevention by vitamin A of the occurrence of permanent vaginal and uterine changes in ovariectomized adult mice treated neonatally with diethylstibestrol and its nullification in the presence of ovaries
- PMID: 4018158
- DOI: 10.1055/s-0029-1210428
Prevention by vitamin A of the occurrence of permanent vaginal and uterine changes in ovariectomized adult mice treated neonatally with diethylstibestrol and its nullification in the presence of ovaries
Abstract
Permanent proliferation and cornification of the vaginal epithelium occurred in adult ovariectomized (OVX) mice which had received neonatal injections of 5 micrograms diethylstilbestrol (DES). Occurrence of the permanent epithelial proliferation was prevented by injections of 200 IU vitamin A acetate (VA) given simultaneously with neonatal DES-treatment in mice when OVX at 30 days of age, but not in those OVX at 270 days. For the suppression of the permanent vaginal changes, however, more than one month were required after DES plus VA-treatment. In DES plus VA-treated OVX (at 30 days) mice, the vaginal epithelium indicated a lower mitotic rate than in DES-treated OVX mice. Clear cells were found in the degenerating vaginal epithelium in 63% of DES plus VA-treated OVX mice, while in the proliferated epithelium, this type of cells appeared only in 10% of DES-treated OVX mice. In 40% of 180-day-old, DES-treated OVX (at 30 days) mice, permanent stratification took place in the uterine epithelium, while it was inhibited in the age-matched DES plus VA-treated OVX mice. However, the uterine change was not prevented in 310-day-old, DES plus VA-treated mice when OVX at 270 days. This findings suggests that the relatively long-term presence of ovaries nullifys the inhibitory effect by VA on the occurrence of permanent changes in the utero-vaginal epithelium induced by neonatal DES treatment.
Similar articles
-
Effects of postpubertal treatment with diethylstilbestrol and tamoxifen on protein expression in the vagina and uterus of neonatally diethylstilbestrol-exposed mice.In Vivo. 1992 May-Jun;6(3):271-8. In Vivo. 1992. PMID: 1391694
-
Morphological effects of diethylstilbestrol on neonatal mouse uterus and vagina.Cancer Res. 1981 Nov;41(11 Pt 1):4667-77. Cancer Res. 1981. PMID: 7306983
-
Vitamin A prevents the irreversible proliferation of vaginal epithelium induced by neonatal injection of keratinocyte growth factor in mice.Cell Tissue Res. 2003 Feb;311(2):251-8. doi: 10.1007/s00441-002-0667-z. Epub 2002 Dec 14. Cell Tissue Res. 2003. PMID: 12596044
-
Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium.Natl Cancer Inst Monogr. 1979 May;(51):41-56. Natl Cancer Inst Monogr. 1979. PMID: 384264 Review.
-
Cytological basis for permanent vaginal changes in mice treated neonatally with steroid hormones.Int Rev Cytol. 1976;44:193-224. doi: 10.1016/s0074-7696(08)61650-2. Int Rev Cytol. 1976. PMID: 770369 Review. No abstract available.
Cited by
-
Mice lacking membrane estrogen receptor 1 are protected from reproductive pathologies resulting from developmental estrogen exposure†.Biol Reprod. 2019 Aug 1;101(2):392-404. doi: 10.1093/biolre/ioz090. Biol Reprod. 2019. PMID: 31141131 Free PMC article.
-
Regulation of AKT Signaling in Mouse Uterus.Endocrinology. 2022 Jan 1;163(1):bqab233. doi: 10.1210/endocr/bqab233. Endocrinology. 2022. PMID: 34791100 Free PMC article.
-
RA-RAR signaling promotes mouse vaginal opening through increasing β-catenin expression and vaginal epithelial cell apoptosis.Reprod Biol Endocrinol. 2023 Apr 11;21(1):36. doi: 10.1186/s12958-023-01084-8. Reprod Biol Endocrinol. 2023. PMID: 37041518 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical